These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 36618408)
1. Manipulating T-cell metabolism to enhance immunotherapy in solid tumor. Chen C; Wang Z; Ding Y; Qin Y Front Immunol; 2022; 13():1090429. PubMed ID: 36618408 [TBL] [Abstract][Full Text] [Related]
2. Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment. Zhang L; Pakmehr SA; Shahhosseini R; Hariri M; Fakhrioliaei A; Karkon Shayan F; Xiang W; Karkon Shayan S Med Oncol; 2023 Dec; 41(1):8. PubMed ID: 38062315 [TBL] [Abstract][Full Text] [Related]
3. Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity. Zhang S; Zhang X; Yang H; Liang T; Bai X Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189022. PubMed ID: 37993001 [TBL] [Abstract][Full Text] [Related]
4. The Complex Integration of T-cell Metabolism and Immunotherapy. Madden MZ; Rathmell JC Cancer Discov; 2021 Jul; 11(7):1636-1643. PubMed ID: 33795235 [TBL] [Abstract][Full Text] [Related]
5. Oncolytic Viruses: Priming Time for Cancer Immunotherapy. Russell L; Peng KW; Russell SJ; Diaz RM BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623 [TBL] [Abstract][Full Text] [Related]
6. Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy. Wang S; Wei J Int J Cancer; 2022 Nov; 151(10):1654-1662. PubMed ID: 35633046 [TBL] [Abstract][Full Text] [Related]
7. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy. Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067 [TBL] [Abstract][Full Text] [Related]
8. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. Schirrmacher V; van Gool S; Stuecker W Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361831 [TBL] [Abstract][Full Text] [Related]
9. The cancer metabolic reprogramming and immune response. Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704 [TBL] [Abstract][Full Text] [Related]
10. Metabolic plasticity of T cell fate decision. Pan X; Wang J; Zhang L; Li G; Huang B Chin Med J (Engl); 2024 Apr; 137(7):762-775. PubMed ID: 38086394 [TBL] [Abstract][Full Text] [Related]
11. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. Bahrambeigi S; Shafiei-Irannejad V Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044 [TBL] [Abstract][Full Text] [Related]
12. AMPK-a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment? Wang N; Wang B; Maswikiti EP; Yu Y; Song K; Ma C; Han X; Ma H; Deng X; Yu R; Chen H Cell Death Discov; 2024 May; 10(1):237. PubMed ID: 38762523 [TBL] [Abstract][Full Text] [Related]
13. Immunometabolism: A new target for improving cancer immunotherapy. Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359 [TBL] [Abstract][Full Text] [Related]
14. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Groeneveldt C; Kinderman P; van den Wollenberg DJM; van den Oever RL; Middelburg J; Mustafa DAM; Hoeben RC; van der Burg SH; van Hall T; van Montfoort N J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082167 [TBL] [Abstract][Full Text] [Related]
15. Advances in reprogramming of energy metabolism in tumor T cells. Xuekai L; Yan S; Jian C; Yifei S; Xinyue W; Wenyuan Z; Shuwen H; Xi Y Front Immunol; 2024; 15():1347181. PubMed ID: 38415258 [TBL] [Abstract][Full Text] [Related]
16. New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment. Sung JY; Cheong JH Cells; 2022 Feb; 11(5):. PubMed ID: 35269390 [TBL] [Abstract][Full Text] [Related]
17. Targeting metabolism to enhance immunotherapy within tumor microenvironment. Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X Acta Pharmacol Sin; 2024 Oct; 45(10):2011-2022. PubMed ID: 38811773 [TBL] [Abstract][Full Text] [Related]
18. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826 [TBL] [Abstract][Full Text] [Related]
19. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235 [TBL] [Abstract][Full Text] [Related]
20. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses. Crupi MJF; Bell JC; Singaravelu R Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]